Leadership is one of ASPIRE’s core strengths as key management have the requisite passion, commitment, and experience in making ASPIRE successful.
Dr. Gina Ogilvie, MD, MSc, FCFP, DrPH, is a Tier 1 Canada Research Chair in Global control of HPV related disease and Professor at the University of British Columbia. Gina is co-principal investigator on a $6 million Canadian Institute of Health Research grant examining HPV testing and principal investigator of ASPIRE. She has developed expertise in HPV, cervical cancer, HPV vaccine, HIV primary care, colposcopy, care for marginalized populations and sexually transmitted diseases. Gina’s remarkable networking skills ensure solid stakeholder relationships and continued support from partners in Canada and East Africa. Gina will continue to keep the ASPIRE program on course with the latest scientific developments on the cervical cancer prevention and treatment front.
Dr. Deborah Money, BSc, MD, FRCSC, is a Professor at the University of British Columbia in the Department of Obstetrics and Gynecology and is a subspecialist in Reproductive Infectious Diseases. She is a globally recognized expert in the field of HPV and has developed clinical and research programs in Reproductive Infectious Diseases with research focused on HIV and other viral infections in pregnancy, HPV and the HPV vaccine in the prevention of cervical cancer and most recently in genome based studies of the vaginal microbiome. Dr. Money brings expertise and understanding of the relevant study population and an appreciation of the clinical relevance and potential application of the anticipated study outcomes as well as their potential impact on reproductive health. Dr. Money is Vice President, Research, BC Women’s Hospital and was the first Canadian President of the Infectious Diseases Society of Obstetrics and Gynecology (IDSOG) [a US based organization].
Dr. Jan Christilaw, MD, MHSc, is President of BC Women’s Hospital & Health Centre and is a co-leader of the Provincial Women’s Health Network. Jan’s contributions to women’s health services in Canada have been extraordinary. In 2007 she won the Federation of Medical Women of Canada’s national leadership award. Jan has been interested in international women’s health for many years working internationally on a number of projects, including partnerships with Makerere University in Uganda for services in maternal and child health. She is one of the key administrative leads for ASPIRE and content expert in -training in colposcopy.
Dr. Christine Biryabarema, MD, MSc, is a Former Head of the Department of Obstetrics/Gynaecology at Mulago Hospital and a Faculty member at Makerere University. She is an experienced clinician and continental leader in Women’s Health who will act as a key African advisor for ASPIRE.
Dr. Sheona Mitchell, MD, MPH, FRCSC, is an Obstetrician Gynecologist and Assistant Professor with UBC and the Northern Medical Program in Prince George. She has conducted research in Tanzania with CIDA and contributed to several research projects in South America. Dr. Mitchell coordinated ASPIRE’s acceptability and attitudes survey in May 2011 and the pilot feasibility study. She is fluent in Swahili and is quickly developing her Luganda through her work in Kisenyi.
Dr. Musa Sekikubo, MBChB, MMED, is an experienced clinician, specialist in obstetrics and gynaecology, and lecturer at Makerere University. Musa will facilitate training in colposcopy, and co-conduct community awareness workshops.
Erin Moses, RN, MPH, is a Registered Nurse with extensive work experience in the Middle East and Africa. In 2013 she coordinated a pilot randomized controlled trial exploring optimal methods for cervical cancer screening in Uganda with ASPIRE. Erin completed her MPH at the University of Toronto and is has a particular interest on the impact of research on policy development.
Dr. Diane Miller, BSc, MD, FRCSC, is the Division Head of Gynecologic Oncology in the Department of Obstetrics and Gynecology at the University of British Columbia and gynaecologic oncologist at Vancouver General Hospital. She is also the Provincial Gynecology Tumor Group Chair for the Province of British Columbia and a member of Vancouver Coastal Health Reserach Institute. Dr. Miller obtained her BSc. in microbiology and immunology at UBC in 1976, her MD at UBC in 1980. She then interned at the Toronto Western Hospital prior to working as a Family Doctor in Yellowknife NWT. In 1988, Dianne completed her Royal College certification in Obstetrics and Gynecology at UBC. This was followed by completion of a Royal College Fellowship in Gynecologic Oncology in Toronto in 1990. Dianne has been employed at the British Columbia Cancer Agency and UBC since that time. Dr. Miller is actively involved in both clinical trials and in collaborations with translational and basic scientists. She is particularly interested in looking potential screens for early diagnosis and in targeted therapies.
Ian Roe, B.Comm, PBacc Communications, is a British Columbia Centre for Disease Control Health Promotions and Communications expert. Ian brings an exceptional track record in public health education, promotion, communications and messaging. He is also a documentary film maker.
Dr. Mel Krajden, MD, FRCP(C), is the Medical Head, Hepatitis, Clinical Prevention Services at the British Columbia Centre for Disease Control, Associate Medical Director, BCCDC Public Health Microbiology and Reference Laboratory, and Associate Professor of Medical Microbiology in the Department of Pathology and Laboratory Medicine at the University of British Columbia. He is an internationally known virologist, with vast experience in HPV as well as HIV and Hepatitis C.
Dr. Malcolm Steinberg, MD, MSc, is a Physician Epidemiologist with Clinical Prevention Services at the BC Centre for Disease Control, Clinical Professor, Director of Public Health Practice, and Chair of the MPH Program in the Faculty of Health Sciences at Simon Fraser University. He has over 20 years experience in global health in Africa and South East Asia. Malcolm was born and raised in South Africa. His African roots, considerable work experience on the continent, and experience in community mobilization and health care reform initiatives will strengthen opportunities for the ASPIRE program to maximize community participation and achieve integration into health systems.
Doreen Birungi, BA, works for the ASPIRE program in Kampala, Uganda, under the supervision of Drs. Christine and Musa. She has experience in community outreach and office administration. She currently acts as a liaison with community volunteers in Kisenyi, and assists with program design and research. Doreen is ASPIRE’s link to Mulago Hospital (where she has an office) and coordinator of the program.
Dr. Joel Singer, PhD, is a professor in the School of Population and Public Health at the University of British Columbia, and is the Programme Head of the Canadian Institute for Health Research, Canadian HIV Trials Network. He is an epidemiologist and statistician who specializes in clinical trials methodology and clinical trials in HIV/AIDS.
Dr. Dirk van Niekirk, MB, ChB, Mmed, FFPath, LMCC, FRCPC, is the Medical Leader of Cervical Cancer Screening at the BC Cancer Agency, and a clinical assistant professor in the Department of Pathology and Laboratory Medicine at the University of British Columbia.
Dr. Josaphat Byamugisha, is the Chief Department of Obstetrics and Gynecology at Makerere University
Dr. Florence Mirembe, is a consultant gynecologist at Mulago and Associate Professor at Makerere University. She is a leader in women’s health in Uganda and acts in an advisory role to the project.
Dr. Marette Lee MD, FRCSC, is a Gynecologic Oncologist at the Vancouver General Hospital and BC Cancer Agency. She is also currently working on an MPH at the Johns Hopkins School of Public Health. She has a particular interest in the lower genital tract and HPV, and she is involved in guideline and program development for colposcopy in British Columbia.
Dr. Flora Fang-Hwa Teng, BSc, MD, MPH, is a Chief Resident in Obstetrics and Gynecology at the University of British Columbia. She has conducted clinical and health services research in cardiovascular health, infectious disease, and ovarian cancer. In May of 2012, Dr. Teng conducted a qualitative study on the role of embarrassment in HPV Self-Collection in Uganda. Dr. Teng completed her MPH at Yale University and is currently working with ASPIRE team to explore the impact of an HPV diagnosis on quality of life.